Search
Menu
Pharming Group N.V. announces that at its Annual General Meeting of shareholders (AGM), held today, all proposals were approved.
The information contained in the section of Pharming Group N.V.’s (the "Company") website that you are attempting to access is not intended for, and must not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in the United States of America (including its territories and possessions, any state of the United States and the District of Columbia, the "United States"), Canada, Australia, South Africa, Japan or any jurisdiction where action for that purpose is required or where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction, and does not constitute an offer to sell or the solicitation of an offer to buy or acquire, any ordinary shares or other securities of the Company in the United States or any jurisdiction where action for that purpose is required or where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.
The securities of the Company referred to on the following web page (the "Securities") have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of the Securities in the United States.
The Securities have also not been and will also not be registered under the applicable securities laws of Canada, Australia, South Africa, or Japan and, subject to certain exemptions, may not be offered or sold in or into or for the account or benefit of any person having a registered address in, or located or resident in Canada, Australia, South Africa, or Japan. There will be no public offer of the Securities in Canada, Australia, South Africa, or Japan.
Access to the information and documents contained on the following website may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access such information and documents. All persons residing outside of the Netherlands who wish to have access to the documents contained on this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. No such registration or approval has been obtained outside the Netherlands. The Company assumes no responsibility if there is a violation of applicable law and regulations by any person.
The contents of this website are not to be incorporated into, or construed to form part of, any of the documents included herein. Except as otherwise explicitly stated herein as applicable to them, no information included on this website should be used by investors in forming their investment decision as to an investment in the Securities.
The use of this section of the website is subject to Dutch law and any disputes arising out of or regarding this section of the website is subject to Dutch law and the exclusive jurisdictions of the Dutch courts.
I therefore certify that:
I am resident and physically present (a) outside the United States, Canada, Australia, South Africa, and Japan; (b) in the Netherlands; or (c) outside the Netherlands, the United States, Canada, Australia, South Africa, and Japan, and in such case, I am authorized to access the information and documents on this website without being subject to any legal restriction and without any further action required by the Company. I have read, understand and agree to comply with all of the restrictions set forth above.
Wilt u overschakelen naar een andere taal? Klik hier voor de Nederlandse website.